LONI: Laboratory of Neuro Imaging

Childhood Onset Schizophrenia

OVERVIEW
Schizophrenia is a debilitating psychiatric disorder that affects 1% of adult Americans. Often striking without warning in the late teens or early twenties, its symptoms include visual and auditory hallucinations, psychotic outbreaks, bizarre or disordered thinking, as well as depression and social withdrawal. The childhood-onset form of the disorder is similar to the adult-onset form in many ways, but it is more severe.

Childhood onset schizophrenia affects about 1 child in 40,000, compared to 1 in 100 in adults. Children with schizophrenia experience difficulty in managing everyday life. They share with their adult counterparts hallucinations, delusions, social withdrawal, flattened emotions, increased risk of suicide and loss of social and personal care skills. They may also share some symptoms with—and be mistaken for—children who suffer from autism or other pervasive developmental disabilities, which affect about 1 in 500 children. Children with schizophrenia tend to be harder to treat and have a worse prognosis than adult-onset schizophrenia patients.

DIAGNOSIS

While schizophrenia generally begins as an acute psychotic episode in young adults, it appears to emerge more gradually in children. The appearance of the disorder is often preceded by developmental disturbances, such as lags in motor and speech/language development. These developmental problems can often be associated with more distinct brain abnormalities.

The diagnostic criteria are the same as for adults (read more about schizophrenia), except that symptoms appear prior to age 12. Children with schizophrenia frequently see or hear things that don't really exist, and often hold paranoid and bizarre beliefs. These symptoms may be accompanied by attention problems, impaired memory and reasoning, speech impairments, inappropriate, or flattened affect, poor social skills, and depressed mood. Misdiagnosis of schizophrenia in children is common. Symptoms are prevalent in the child's life and are not limited to specific situations. Children with schizophrenia tend to be cut off from normal relationships and are unlikely to show any interest in friendships with others.

CAUSES
It is commonly held that both genetic and environmental factors contribute to the development of schizophrenia Although it's unclear whether it has a single or multiple underlying causes, evidence strongly supports the theory that it is a neurodevelopmental disease likely involving a genetic predisposition, a prenatal insult to the developing brain and stressful life events. Recent research has shown that children share with adults many of the same abnormal brain structural, physiological and neuropsychological features associated with schizophrenia. Children seem to have more severe cases than adults, with more pronounced neurological abnormalities.

CURRENT RESEARCH

Since 1992 researchers at the National Institute of Mental Health in Bethesda have scanned over 1,000 children and adolescents with high-resolution brain MRIs. What makes this study unique is the fact that these children return to the clinic to be re-scanned every 2 years. Many children are now receiving their 5th scan, and have grown up in the meantime, leaving a remarkable time-lapse movie as record of how their brain has developed. The resulting treasure-chest of brain scans charts brain growth in unprecedented detail. Among those patients scanned at NIMH were 40 adolescents with early-onset schizophrenia (EOS), who were scanned repeatedly as their disorder developed. These patients had detailed cognitive and clinical evaluations; they satisfied DSM-III-R/DSM-IV criteria for diagnosis of schizophrenia before the age of 12. Since their symptoms are continuous with the adult disorder, their brain scans and repeated neuropsychiatric tests hold key information on how schizophrenia develops in the teenage years.

In a longitudinal brain imaging study of adolescents, MRI scans revealed fluid filled cavities in the middle of the brain enlarging abnormally between ages 14 and 18 in teens with early onset schizophrenia, suggesting a shrinkage in brain tissue volume. These children lost four times as much gray matter, neurons and their branch-like extensions, in their frontal lobes as normal teens. This gray matter loss engulfs the brain in a progressive wave from back to front over 5 years, beginning in rear structures involved in attention and perception, eventually spreading to frontal areas responsible for organizing, planning, and other "executive" functions impaired in schizophrenia. Since losses in the rear areas are influenced mostly by environmental factors, the researchers suggest that some non-genetic trigger contributes to the onset and initial progression of the illness. The final loss pattern is consistent with that seen in adult schizophrenia. Adult-onset patients' brains may have undergone similar changes when they were teens that went unnoticed because symptoms had not yet emerged, suggest the researchers.

RESEARCH AT LONI
In recent collaborations with the NIMH team, we have aimed to develop extremely sensitive methods to map changes in the developing brain. The goal is to visualize where the brain is growing fastest, measuring local growth rates and their statistics, and revealing where gray matter or other types of tissue are lost. By combining and comparing data from multiple subjects, we have created detailed color-coded maps to uncover where and how fast these changes occur, and where the brain changes most prominently in disease.

 
Mapping Brain Changes in Schizophrenia.
Derived from high-resolution magnetic resonance images (MRI scans), the above images were created after repeatedly scanning 12 schizophrenia subjects over five years, and comparing them with matched 12 healthy controls, scanned at the same ages and intervals. Severe loss of gray matter is indicated by red and pink colors, while stable regions are in blue. STG denotes the superior temporal gyrus, and DLPFC denotes the dorsolateral prefrontal cortex. (Reprinted with permission from Thompson PM et al., Proceedings of the National Academy of Sciences of the USA, 98[20]:11650-11655)
 

In studying the schizophrenic patients, we were stunned to see a spreading wave of tissue loss that began in a small region of the brain, the parietal cortices (see accompanying image, top row, red colors). This deficit pattern, which we recently reported in the Proceedings of the National Academy of Sciences, moved across the brain like a forest fire. It destroyed more tissue as the disease progressed (red colors, bottom row), eventually engulfing the rest of the cortex after a period of 5 years. The 3D maps are color coded to show different degrees of change, revealing where gray matter is significantly reduced in disease.

Methods
At each scan, 12 schizophrenic patients were compared with 12 healthy controls matched for age, gender, and demographics. In each scan, a measure of the local quantity of gray matter was made at each point on the cerebral cortex, and changes were mapped in both patients and controls.
 
Results

At their first scan (an average of 1.5 years after initial diagnosis), patients showed a 10% gray matter deficit in a small region of the cortex. This deficit, observed at the age of 13, was initially confined to parietal brain regions involved in spatial association. Over the 5 succeeding years, this brain tissue loss swept forward into sensory and motor regions, and by the age of 18, into dorsolateral prefrontal and temporal cortices, which were not initially affected. This pattern was replicated in independent groups of male and female patients. Each showed a similar pattern of spreading deficits, reaching a 20%-25% average loss. Overall, regions of loss corresponded with the impairments in neuromotor, auditory, visual search, and frontal executive functions that characterize schizophrenia. The frontal eye fields lost tissue fastest, at about 5 percent per year, perhaps consistent with the eye-tracking and smooth eye pursuit deficits often reported in patients.

 
Clinical Symptoms

This dynamic wave of brain tissue loss also correlated with worsening psychotic symptoms and mirrored the progression of neurological and cognitive deficits associated with the disorder. Specifically, patients with fastest loss in temporal cortices had worst positive symptoms (including hallucinations and delusions). Since temporal loss rates were a good predictor of positive symptoms at follow-up, future studies in larger samples will be able to assess whether these losses link more specifically with auditory rather than visual hallucinations. In addition, gray matter loss in the frontal cortices correlated with increased negative symptoms (such as lack of emotional responses and poverty of speech). The resulting deficits are consistent with the physiological hypothesis that negative symptoms of schizophrenia may partly derive from reduced dopaminergic activity in frontal cortices. We are currently developing digital mapping methods to isolate which specific frontal deficits (e.g., dorsolateral prefrontal, orbitofrontal) link most tightly with negative symptoms.

 
Medication Effects
We also wanted to address the possibility that drug treatment may have induced these patterns of gray matter loss in the schizophrenic patients. So we also mapped 10 IQ-matched, serially imaged non-schizophrenic subjects, who received identical medication to the patients (primarily for control of chronic mood disorders and aggressive outbursts). While the non-schizophrenic group did show some subtle but significant tissue loss, this was much less marked than for the schizophrenics, and was restricted to superior frontal cortices. No temporal lobe or pervasive frontal deficits were observed in the medication controls, suggesting that the wave of disease progression may be specific to schizophrenia, regardless of medication, and also regardless of gender or IQ.
 
Genetics
With the recent discovery of several candidate genes that affect individual risk for schizophrenia, specific genetic factors may soon be implicated in causing this deficit pattern, or at least in increasing susceptibility to the illness. Relatives who are genetically closer to a schizophrenic patient are more likely to develop the disorder themselves, and there is considerable interest in determining individual relatives' risk for the disease, as well as understanding its genetic transmission. Recently, we developed a technique to visualize genetic influences on brain structure. This technique determines which aspects of brain structure we inherit from our parents, which are therefore similar among family members. This genetic brain mapping approach also links structure features that can be measured from a brain scan with behavioral traits such as IQ, and even genetically transmitted deficits. To examine the genetic transmission of deficits in schizophrenia, we recently measured differences in cortical gray matter between monozygotic (MZ) twins discordant for schizophrenia. These twins are genetically identical, but only one twin per pair has the disorder. Since only 48% of the MZ twins of a patient ever develop schizophrenia, genes are not all-important in producing the disease. In the identical twins we examined, the schizophrenic member of each pair showed statistically significant gray matter reductions (between 5-8%) in superior parietal cortices and dorsolateral prefrontal cortices, and in the superior temporal gyrus of the left hemisphere. There were no significant differences between the discordant co-twins in primary somatosensory or primary motor areas. Since the MZ twins were identical genetically, the early loss of parietal cortex in the EOS patients suggests an environmental rather than a genetic origin for the disease. In the frontal and temporal regions, however, where loss occurred relatively late in the EOS patients, deficits were
 
Future Research
New imaging methods, including those linking brain deficits with specific risk genes, are likely to be at the forefront in discovering the triggers of schizophrenia. Imaging methods also show promise for early detection of the disease, especially in relatives who are at genetic risk. Patients may then be treated at the earliest possible opportunity, before the ravages of the disease have set in.
 
IN THIS SECTION:
RELATED LINKS:
LONI Copyright Reserved